Ethosuximide

DB00593ApprovedInvestigationalSmall moleculeAnti-epileptic Agent

Ethosuximide is an anticonvulsant used to treat petit mal seizures. An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.

Chemical structure of Ethosuximide
Mechanism
Curator reviewed
Primary indication
For the treatment of petit mal epilepsy.Curator reviewed · 1 structured indication
Formula / weight
C7H11NO2 · 141.1677 g/mol (avg)
First approval
Canada, 2022 · United States, 1994
Also known as
Atysmal · Thilopemal
Code names
CI-366 · CN-10,395 · PM-671
Brand names
  • Zarontin

Resolves to

Structure
InChIKeyHAPOVYFOVVWLRS-UHFFFAOYSA-NSMILESCCC1(C)CC(=O)NC1=O

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,672Drug interactionsStructured to mechanism, not free text
Sign in
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
38Marketed productsAcross 5 countries and 27 labellers
Sign in
2ATC codesIncluding every combination product, plus 22 drug categories
Sign in
16+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ethosuximide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account